Paricalcitol Capsules — Class II drug recall D-0774-2016
Terminated recall by Teva Pharmaceuticals USA, reported 2016-03-23, distributed nationwide. Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stabilit
| Recall number | D-0774-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2016-02-05 |
| Classified | 2016-03-11 |
| Reported by FDA | 2016-03-23 |
| Terminated | 2017-01-13 |
| Distributed | Nationwide (US) |
| Quantity | 30,891 bottles |
| Reason classes | specification failure |
| NDC | 00093-7656-56 |
| Lot numbers | 13013.009A |
| Expiration dates | 2016-02 |
Product
Paricalcitol Capsules, 1 mcg, 30 tablets per Bottle, Rx Only, Manufactured By: Pharmaceutics International, Inc., Hunt Valley, MD 21031, Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7656-56.
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0774-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.